[
THE INVESTOR] As of Sept. 26 12:40 P.M., NICE TCM increased 2.91%, compared with yesterday, to 10,250 won. It had declined 8.07% through the past month. Standard deviation, which indicates risk, records 2.9% over the same period over one month.
Compared with its close competitors within the same industry, KOSDAQ, not only the monthly earnings rate of NICE TCM had edged along, but its volatility for 1 month was also the highest among its peer group's. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -2.7%. Though the volatility was the highest among its peer group, the return-on-risk remain around the average of its peer group, caused by low de However, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -1.8, and thus it is hard to say that the industrial comparison performance was positive.
By HeRo (
hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp